A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.
Mohmaed Ali MI, Nijstad AL, Boosman RJ, Crombag MBS, Barnett S, Veal GJ, Lalmohamed A, van Erp NP, Steeghs N, Zwaan CM, Beijnen JH, Siebinga H, Huitema ADR.
Mohmaed Ali MI, et al. Among authors: beijnen jh.
Clin Pharmacokinet. 2024 Nov 16. doi: 10.1007/s40262-024-01445-5. Online ahead of print.
Clin Pharmacokinet. 2024.
PMID: 39549227